About

Sharing the founder’s journey and scientific achievements to inspire the leaders of tomorrow. On each episode, the host Serghei Glinca, biotech entrepreneur and ecosystem builder, meets unconventional founders to talk about science, entrepreneurship, fundraising, and leadership. The shared lessons of the founder’s journey show a clear path how to take action and activate talents to start their own journey as founders. Serghei and guests also discuss practical perspectives and tools to motivate the scientific community to turn science into tangible impact.

Maria Soloveychik on synthetic biology for discovery of protein interaction modulators
Maria Soloveychik on synthetic biology ...
Maria Soloveychik is the co-founder and CEO of SyntheX, a therapeutics company accelerating drug discovery through...
00:59:12
November 07, 2024
Christoph Lengauer on building visionary biotech companies
Christoph Lengauer on building visionar...
Christoph Lengauer has contributed to the development of 10 FDA-approved cancer medicines. Christoph is Chief Scie...
00:52:21
October 25, 2024
Deep dive into business development in biotech with James Lee
Deep dive into business development in ...
Business development is an essential process for biotech companies to build relationships with partners and create...
00:28:31
January 18, 2024
James Lee on the vital role of business development for biotech companies
James Lee on the vital role of business...
James Lee received his B.S and M.S. in Structural Biology from Seoul National University, he held various roles in...
00:31:49
January 05, 2024
Yaniv Erlich on building a scalable platform to discover next-gen RNA therapeutics.
Yaniv Erlich on building a scalable pla...
Prof. Yaniv Erlich received his bachelor’s degree from Tel-Aviv University, Israel in 2006 and a PhD from the Wa...
01:01:18
October 04, 2023
Kiyoshi Takayama on targeting challenging GPCRs using monoclonal antibodies
Kiyoshi Takayama on targeting challengi...
Kiyoshi Takayama has received a Ph.D. in pharmaceutical science from the University of Tokyo. After his PhD he wor...
00:53:26
August 09, 2023
David Younger on how synthetic biology helps to identify molecular glues
David Younger on how synthetic biology ...
David Younger is a bioengineer and started his biotech journey directly after his PhD. David’s scientific resear...
00:39:09
November 18, 2022
Elaine Hamm on overcoming the “shiny object syndrome” in biotech
Elaine Hamm on overcoming the “shiny ...
The path from the lab bench to market in biotech has many hurdles and lots of opportunities. Sometimes too many. E...
00:45:29
October 06, 2022
Deep dive into targeted protein degradation and PROTACs with Alessio Ciulli
Deep dive into targeted protein degrada...
Targeted protein degradation, TPD, is a new and disruptive therapeutic approach for development of medicines. TPD ...
00:22:35
September 08, 2022
Alessio Ciulli on the next level of small molecules as thrapeutics: PROTACs
Alessio Ciulli on the next level of sma...
Targeted protein degradation, or TPD, is a new and disruptive therapeutic approach for development of medicines. T...
00:42:27
August 19, 2022
Mark Tebbe on ultradeep chemoproteomics and machine learning for covalent drug discovery
Mark Tebbe on ultradeep chemoproteomics...
Mark Tebbe started his career as an organic chemist and later had senior positions at Lilly. After 16 years of a s...
00:30:45
August 04, 2022
Carlo Bertozzi on building a mission-driven biotech company
Carlo Bertozzi on building a mission-dr...
Carlo started his biotech journey as a founder and G7 Therapeutics as a spin-off from the University of Zurich. Th...
00:31:23
June 30, 2022
About founders in biotech
About founders in biotech
As a founder, Serghei experienced the challenges of building a company in the fragmented biotech ecosystem. Giving...
00:01:05
June 20, 2022

our partners

imprint